Who We Are

This “has huge implications not just for infectious disease but also for cancer and ageing in general.”
-Dr. Sam Palmer

"It has never been shown before that predicted biological age…can be reversed over time in the same individuals, and especially so after an intervention of this kind."
- Dr. Sara Hägg, Karolinska Institute

Greg Fahy

Greg Fahy, PhD, Chief Scientific Officer, Co-founder

-Designed and led the TRIIM trial; Published the first report of thymus regeneration in a normal human; Granted patents on methods for and applications of human thymus regeneration

–Fellow of the American Aging Association (since 2005), Former Director of the American Aging Association (16 years)

–Editor-in-Chief, The Future of Aging: Pathways to Human Life Extension

–Awarded the Society for Cryobiology’s Luyet Medal in 2016

–In 2009, showed indefinite survival of rabbit kidney transplanted after cooling to -130° Celsius; Led 21CM team as co-winner of Small Mammal Brain Preservation Prize, 2018 winner of Large Mammal Brain Preservation Prize

Steve Horvath, PhD, Scientific Collaborator

-Professor of Human Genetics & Biostatistics at UCLA

-Developer of the DNA methylation clock of human aging, as well as author of seminal papers demonstrating ability to accurately predict life expectancy, onset of Alzheimer's, cognitive decline, and more

-Paul G. Allen Distinguished Investigator

-Ph.D. Mathematics at UNC, Sc.D. Biostatistics from Harvard University

Steve Horvath

Robert (Bobby) Brooke, Chief Executive Officer, Co-founder

-Managed TRIIM trial, including coordination of all regulatory approvals and collaborations

-Serial biotech entrepreneur: Founder of cancer immunotherapy company now known as Iovance Biotherapeutics (NASDAQ:IOVA),  Co-founder of cannabinoid drug development company, Vitality Biopharma

-Former hedge fund investment analyst with Bristol Capital Advisors, a direct investor in more than 50 healthcare and biotech companies

-Bioengineer from Georgia Tech & UCLA; Co-inventor on recent patent applications including for GI-targeted drug delivery

Paul Hynek, MBA, Chief Financial Officer

-Adjunct Professor, Pepperdine University

        -MBA from Univ. of Pennsylvania Wharton School

-Founder/President, EZ Numbers

-Former Director of Business Affairs, Giant Studios, involved with Avatar, Tintin, Lord of the Rings, I Am Legend, Iron Man, Call of Duty, Halo, etc.

-Former Board Chair of American Red Cross of Santa Monica, Board memberships with Raw Science, BRINK Institute, and Lifeboat Foundation

-TRIIM Trial Volunteer

About Us

Intervene Immune is dedicated to achieving a better understanding of the fundamental biology of aging and applying this new knowledge into the practice of medicine today.  For information about current job openings, please contact us at: info@interveneimmune.com.  

If you are interested in our thymus regeneration and immune monitoring programs, contact us today at (833) 3-IMMUNE. Contact Us